ROP
53
-9
LMT
30
-2
TDC
67
-4
PEG
62
4
MNST
45
-21
AN
50
-5
SEE
53
3
K
51
-3
ISRG
71
-5
OMC
50
-16
BBY
52
6
R
70
-3
FSLR
44
-2
DLTR
38
-4
LEN
50
-2
UAL
83
-2
ALL
50
2
NVDA
52
-5
GME
66
-5
PEP
39
-9
ROP
53
-9
LMT
30
-2
TDC
67
-4
PEG
62
4
MNST
45
-21
AN
50
-5
SEE
53
3
K
51
-3
ISRG
71
-5
OMC
50
-16
BBY
52
6
R
70
-3
FSLR
44
-2
DLTR
38
-4
LEN
50
-2
UAL
83
-2
ALL
50
2
NVDA
52
-5
GME
66
-5
PEP
39
-9
Financhill
Back

iShares MSCI Indonesia ETF Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
26

EIDO
iShares MSCI Indonesia ETF

Last Price:
19.97
Seasonality Move:
4.02%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Sell
26
iShares MSCI Indonesia ETF (EIDO) is a Sell

Is iShares MSCI Indonesia ETF a Buy, Sell or Hold?

  • The current iShares MSCI Indonesia ETF [EIDO] share price is $19.97. The Score for EIDO is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
  • EIDO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

EIDO Stock Price Chart

What is iShares MSCI Indonesia ETF's stock price today?

  • The iShares MSCI Indonesia ETF share price today is $19.97
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EIDO is experiencing slight selling pressure.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

EIDO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.51 Sell
Relative Strength Index (14 RSI): 23.64 Sell
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (20.64 - 22.24) Sell
Bollinger Bands (100): (20.18 - 22.38) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

EIDO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 20.44 Sell
20-day SMA: 21.23 Sell
50-day SMA: 21.94 Sell
200-day SMA: 21.28 Sell
8-day EMA: 20.44 Sell
20-day EMA: 21.01 Sell
50-day EMA: 21.44 Sell
200-day EMA: 21.43 Sell

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

iShares MSCI Indonesia ETF Earnings Growth & EIDO Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.35 per share, and an increase next year of $0.56 per share.

iShares MSCI Indonesia ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):